Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP45828.RAIyLy-dXBM9Za5Q0WGPi7qAEa7DPTEXCHdPwNMunosmc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP45828.RAIyLy-dXBM9Za5Q0WGPi7qAEa7DPTEXCHdPwNMunosmc130_assertion type Assertion NP45828.RAIyLy-dXBM9Za5Q0WGPi7qAEa7DPTEXCHdPwNMunosmc130_head.
- NP45828.RAIyLy-dXBM9Za5Q0WGPi7qAEa7DPTEXCHdPwNMunosmc130_assertion description "[The efficacy of LPZ (15 mg/day) as maintenance therapy for erosive RE is influenced by CYP2C19 polymorphism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP45828.RAIyLy-dXBM9Za5Q0WGPi7qAEa7DPTEXCHdPwNMunosmc130_provenance.
- NP45828.RAIyLy-dXBM9Za5Q0WGPi7qAEa7DPTEXCHdPwNMunosmc130_assertion evidence source_evidence_literature NP45828.RAIyLy-dXBM9Za5Q0WGPi7qAEa7DPTEXCHdPwNMunosmc130_provenance.
- NP45828.RAIyLy-dXBM9Za5Q0WGPi7qAEa7DPTEXCHdPwNMunosmc130_assertion SIO_000772 17295875 NP45828.RAIyLy-dXBM9Za5Q0WGPi7qAEa7DPTEXCHdPwNMunosmc130_provenance.
- NP45828.RAIyLy-dXBM9Za5Q0WGPi7qAEa7DPTEXCHdPwNMunosmc130_assertion wasDerivedFrom gad-20130706 NP45828.RAIyLy-dXBM9Za5Q0WGPi7qAEa7DPTEXCHdPwNMunosmc130_provenance.
- NP45828.RAIyLy-dXBM9Za5Q0WGPi7qAEa7DPTEXCHdPwNMunosmc130_assertion wasGeneratedBy ECO_0000203 NP45828.RAIyLy-dXBM9Za5Q0WGPi7qAEa7DPTEXCHdPwNMunosmc130_provenance.